Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannick Van Herck

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Melanoma Research|September 20, 2022
Melanoma cell plasticity poses diagnostic challenges: a case seriesFer Mennens, Yannick Van Herck, Raf Sciot, et al.
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer|May 16, 2024
Navigating next-generation HR<sup>+</sup>/HER2<sup>-</sup> metastatic breast cancer therapies: a critical commentary on abemaciclib <i>vs.</i> tucidinostat after palbociclib progressionPatrick Neven, Lieke Dullens, Sileny Han, et al.
Frontiers in Oncology|April 15, 2021
Multiplexed Immunohistochemistry and Digital Pathology as the Foundation for Next-Generation Pathology in Melanoma: Methodological Comparison and Future Clinical ApplicationsYannick Van Herck, Asier Antoranz, Madhavi Dipak Andhari, et al.
Frontiers in Oncology|August 22, 2022
Next-Generation Pathology Using Multiplexed Immunohistochemistry: Mapping Tissue Architecture at Single-Cell LevelFrancesca Maria Bosisio, Yannick Van Herck, Julie Messiaen, et al.
Current Oncology (Toronto, Ont.)|August 27, 2021
Multitumor Case Series of Germline <i>BRCA1</i>, <i>BRCA2</i> and <i>CHEK2</i>-Mutated Patients Responding Favorably on Immune Checkpoint InhibitorsLisa Kinget, Oliver Bechter, Kevin Punie, et al.
The Lancet. Healthy Longevity|September 13, 2022
Is cancer biology different in older patients?Yannick Van Herck, Annelies Feyaerts, Shabbir Alibhai, et al.
Clinical Genitourinary Cancer|August 18, 2024
Cabozantinib Induces Isolated Hyperbilirubinemia in Renal Cell Carcinoma Patients carrying the UGT1A1*28 PolymorphismSajedeh Mobaraki, Peter Henrik Nissen, Frede Donskov, et al.
Clinical & Translational Immunology|November 19, 2020
Increased IL-10-producing regulatory T cells are characteristic of severe cases of COVID-19Julika Neumann, Teresa Prezzemolo, Lore Vanderbeke, et al.
Elife|February 15, 2020
Functional heterogeneity of lymphocytic patterns in primary melanoma dissected through single-cell multiplexingFrancesca Maria Bosisio, Asier Antoranz, Yannick van Herck, et al.
Cancer Research|July 14, 2022
Mapping the Immune Landscape in Metastatic Melanoma Reveals Localized Cell-Cell Interactions That Predict Immunotherapy ResponseAsier Antoranz, Yannick Van Herck, Maddalena M Bolognesi, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Melanoma Research|September 20, 2022
Melanoma cell plasticity poses diagnostic challenges: a case seriesFer Mennens, Yannick Van Herck, Raf Sciot, et al.
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer|May 16, 2024
Navigating next-generation HR<sup>+</sup>/HER2<sup>-</sup> metastatic breast cancer therapies: a critical commentary on abemaciclib <i>vs.</i> tucidinostat after palbociclib progressionPatrick Neven, Lieke Dullens, Sileny Han, et al.
Frontiers in Oncology|April 15, 2021
Multiplexed Immunohistochemistry and Digital Pathology as the Foundation for Next-Generation Pathology in Melanoma: Methodological Comparison and Future Clinical ApplicationsYannick Van Herck, Asier Antoranz, Madhavi Dipak Andhari, et al.
Frontiers in Oncology|August 22, 2022
Next-Generation Pathology Using Multiplexed Immunohistochemistry: Mapping Tissue Architecture at Single-Cell LevelFrancesca Maria Bosisio, Yannick Van Herck, Julie Messiaen, et al.
Current Oncology (Toronto, Ont.)|August 27, 2021
Multitumor Case Series of Germline <i>BRCA1</i>, <i>BRCA2</i> and <i>CHEK2</i>-Mutated Patients Responding Favorably on Immune Checkpoint InhibitorsLisa Kinget, Oliver Bechter, Kevin Punie, et al.
The Lancet. Healthy Longevity|September 13, 2022
Is cancer biology different in older patients?Yannick Van Herck, Annelies Feyaerts, Shabbir Alibhai, et al.
Clinical Genitourinary Cancer|August 18, 2024
Cabozantinib Induces Isolated Hyperbilirubinemia in Renal Cell Carcinoma Patients carrying the UGT1A1*28 PolymorphismSajedeh Mobaraki, Peter Henrik Nissen, Frede Donskov, et al.
Clinical & Translational Immunology|November 19, 2020
Increased IL-10-producing regulatory T cells are characteristic of severe cases of COVID-19Julika Neumann, Teresa Prezzemolo, Lore Vanderbeke, et al.
Elife|February 15, 2020
Functional heterogeneity of lymphocytic patterns in primary melanoma dissected through single-cell multiplexingFrancesca Maria Bosisio, Asier Antoranz, Yannick van Herck, et al.
Cancer Research|July 14, 2022
Mapping the Immune Landscape in Metastatic Melanoma Reveals Localized Cell-Cell Interactions That Predict Immunotherapy ResponseAsier Antoranz, Yannick Van Herck, Maddalena M Bolognesi, et al.
Pageof 3